High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients

Atherosclerosis

Volumn 161, Issue 2, 2002, Pages 463-467

  Leviev, Ilia ^a   Poirier, Odette ^b   Nicaud, Viviane ^b   Evans, Alun ^c   Kee, Frank ^c   Arveiler, Dominique ^d   Morrisson, Caroline ^e   Cambien, François ^b   James, Richard W ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b INSERM   (France)

^c MONICA Project   (United Kingdom)

^d MONICA Project   (France)

^e MONICA Project   (United Kingdom)

Author keywords

Gene polymorphisms; HDL; LDL; Oxidative stress; Vascular disease

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ISOPROTEIN; LIPID;

ADULT; AGE; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR;

ADULT; ARYLDIALKYLPHOSPHATASE; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY DISEASE; ESTERASES; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; VASCULAR DISEASES;

EID: 0036122850     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00668-2     Document Type: Article

References (38)

1. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein
2. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
3. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidised low density lipoprotein
4. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-R genetic polymorphism
5. Low density lipoprotein oxidation and its pathobiological significance
6. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model
7. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
8. The polymorphism (Gln-Arg192) of the high-density lipoprotein-bound enzyme paraoxonase is an independent cardiovascular risk factor in non-insulin dependent diabetic patients
9. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary heart disease
10. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes
11. 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese
12. Genetic polymorphisms of paraoxonase and the risk of coronary heart disease
13. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus
14. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetic patients
15. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: Results of the Austrian stroke prevention study
16. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: Prospective nested case-control study
17. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with risk of coronary artery disease in Finns
18. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study
19. The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan
20. Human serum paraoxonase/arylesterase
21. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
22. Promoter polymorphisms of the human paraoxonase PON1 gene and serum paraoxonase activities and concentrations
23. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM study
24. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: The ECTIM and PATHROS studies
25. Testing for association between disease and linked marker loci: A log-linear-model analysis
26. Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease
27. The free radical theory of aging matures
28. Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin, or catechin, is associated with reduced susceptibility of LDL to oxidation and to aggregation
29. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat
30. Smoking is associated with reduced serum paraoxonase activity and concentration in coronary artery disease patients
31. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
32. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation
33. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoproteins against lipid oxidation
34. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease
35. The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease
36. Mutations in the human paraoxonase 1 gene: Frequencies, allelic linkages, and association with coronary artery disease
37. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases
38. The promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 patients